These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30974131)

  • 1. Self-emulsifying drug delivery system: Mucus permeation and innovative quantification technologies.
    Abdulkarim M; Sharma PK; Gumbleton M
    Adv Drug Deliv Rev; 2019 Mar; 142():62-74. PubMed ID: 30974131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucus permeating thiolated self-emulsifying drug delivery systems.
    Rohrer J; Partenhauser A; Hauptstein S; Gallati CM; Matuszczak B; Abdulkarim M; Gumbleton M; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2016 Jan; 98():90-7. PubMed ID: 26598209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypsin decorated self-emulsifying drug delivery systems (SEDDS): Key to enhanced mucus permeation.
    Shahzadi I; Dizdarević A; Efiana NA; Matuszczak B; Bernkop-Schnürch A
    J Colloid Interface Sci; 2018 Dec; 531():253-260. PubMed ID: 30036849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zeta potential changing self-emulsifying drug delivery systems: A promising strategy to sequentially overcome mucus and epithelial barrier.
    Nazir I; Fürst A; Lupo N; Hupfauf A; Gust R; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2019 Nov; 144():40-49. PubMed ID: 31505225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SEDDS facilitate cinnamaldehyde crossing the mucus barrier: The perspective of mucus and Caco-2/HT29 co-culture models.
    Cai Y; Liu L; Xia M; Tian C; Wu W; Dong B; Chu X
    Int J Pharm; 2022 Feb; 614():121461. PubMed ID: 35026310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and in vitro characterization of an oral self-emulsifying delivery system (SEDDS) for rutin fatty ester with high mucus permeating properties.
    Cardona MI; Nguyen Le NM; Zaichik S; Aragón DM; Bernkop-Schnürch A
    Int J Pharm; 2019 May; 562():180-186. PubMed ID: 30898639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and in vitro evaluation of zeta potential changing self-emulsifying drug delivery systems for enhanced mucus permeation.
    Suchaoin W; Pereira de Sousa I; Netsomboon K; Lam HT; Laffleur F; Bernkop-Schnürch A
    Int J Pharm; 2016 Aug; 510(1):255-62. PubMed ID: 27329673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and in vitro characterization of a papain loaded mucolytic self-emulsifying drug delivery system (SEDDS).
    Leichner C; Menzel C; Laffleur F; Bernkop-Schnürch A
    Int J Pharm; 2017 Sep; 530(1-2):346-353. PubMed ID: 28782582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-emulsifying peptide drug delivery systems: How to make them highly mucus permeating.
    Griesser J; Hetényi G; Kadas H; Demarne F; Jannin V; Bernkop-Schnürch A
    Int J Pharm; 2018 Mar; 538(1-2):159-166. PubMed ID: 29339247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-carrier systems: Strategies to overcome the mucus gel barrier.
    Dünnhaupt S; Kammona O; Waldner C; Kiparissides C; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2015 Oct; 96():447-53. PubMed ID: 25712487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucus permeating self-emulsifying drug delivery systems (SEDDS): About the impact of mucolytic enzymes.
    Efiana NA; Phan TNQ; Wicaksono AJ; Bernkop-Schnürch A
    Colloids Surf B Biointerfaces; 2018 Jan; 161():228-235. PubMed ID: 29080507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly mucus permeating and zeta potential changing self-emulsifying drug delivery systems: A potent gene delivery model for causal treatment of cystic fibrosis.
    Griesser J; Hetényi G; Federer C; Steinbring C; Ellemunter H; Niedermayr K; Bernkop-Schnürch A
    Int J Pharm; 2019 Feb; 557():124-134. PubMed ID: 30594687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Intestinal Mucus Permeation of Vancomycin via Incorporation Into Nanocarrier Containing Papain-Palmitate.
    Efiana NA; Dizdarević A; Huck CW; Bernkop-Schnürch A
    J Pharm Sci; 2019 Oct; 108(10):3329-3339. PubMed ID: 31136766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and in vitro characterization of self-emulsifying drug delivery system (SEDDS) for oral opioid peptide delivery.
    Zupančič O; Rohrer J; Thanh Lam H; Grießinger JA; Bernkop-Schnürch A
    Drug Dev Ind Pharm; 2017 Oct; 43(10):1694-1702. PubMed ID: 28589736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zeta potential changing self-nanoemulsifying drug delivery systems: A newfangled approach for enhancing oral bioavailability of poorly soluble drugs.
    Arshad A; Arshad S; Alamgeer ; Mahmood A; Hussain Asim M; Ijaz M; Muhammad Irfan H; Rubab M; Ali S; Raza Hashmi A
    Int J Pharm; 2024 Apr; 655():123998. PubMed ID: 38490401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucolytic self-emulsifying drug delivery systems (SEDDS) containing a hydrophobic ion-pair of proteinase.
    Lam HT; Le NN; Phan TNQ; Bernkop-Schnürch A
    Eur J Pharm Sci; 2021 Jul; 162():105658. PubMed ID: 33271277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-emulsifying drug delivery systems: Design of a novel vaginal delivery system for curcumin.
    Köllner S; Nardin I; Markt R; Griesser J; Prüfert F; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2017 Jun; 115():268-275. PubMed ID: 28323109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technological strategies to estimate and control diffusive passage times through the mucus barrier in mucosal drug delivery.
    Newby JM; Seim I; Lysy M; Ling Y; Huckaby J; Lai SK; Forest MG
    Adv Drug Deliv Rev; 2018 Jan; 124():64-81. PubMed ID: 29246855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of SEDDS and Preactivated Thiomer Technology: Incorporation of a Preactivated Thiolated Amphiphilic Polymer into Self-Emulsifying Delivery Systems.
    Hetényi G; Griesser J; Nardin I; Bernkop-Schnürch A
    Pharm Res; 2017 Jun; 34(6):1171-1179. PubMed ID: 28283859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zeta potential changing self-emulsifying drug delivery systems containing phosphorylated polysaccharides.
    Griesser J; Burtscher S; Köllner S; Nardin I; Prüfert F; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2017 Oct; 119():264-270. PubMed ID: 28684278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.